Skip to content
Back to treatments
Allergy & Immunology~76% less than U.S.

Asthma Biologics Treatment

哮喘生物制剂治疗

Duration
3-5 days for assessment and first dose
Recovery
No recovery needed; benefits develop over 4-12 weeks
Average savings
76%
价格对比Price comparison

China versus the U.S.

China
$3,000
Range: $1,000–$5,000
United States
$12,500
Range: $5,000–$20,000
You save
76%
~$9,500 per procedure
China clinical rate
$1,000 – $5,000
$3,000
United States
$5,000 – $20,000
$12,500
You save
~76%
$9,500 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Targeted biologic therapy for severe asthma using monoclonal antibodies including omalizumab (anti-IgE), mepolizumab (anti-IL-5), dupilumab (anti-IL-4/13), and benralizumab. China's top respiratory centers offer comprehensive asthma phenotyping and biomarker-guided biologic selection at substantially lower costs than Western countries. Treatment dramatically reduces exacerbations and steroid dependence in eligible patients with uncontrolled severe asthma.

流程Procedure steps

Step by step.

  1. 01

    Severe Asthma Phenotyping

    Comprehensive evaluation including lung function, FeNO measurement, blood eosinophils, total IgE, allergy testing, and CT imaging

    Duration · 1-2 days
  2. 02

    Biologic Selection

    Based on biomarker profile, specialist selects optimal biologic agent and discusses expected outcomes and administration schedule

    Duration · 1 day
  3. 03

    First Dose Administration

    Subcutaneous injection administered in clinic with 1-2 hour observation period for any injection reactions

    Duration · 2-3 hours
  4. 04

    Treatment Plan & Supply

    Arrangement of ongoing medication supply, training on self-injection if applicable, and steroid tapering schedule

    Duration · 1 day
Benefits
  • Biologics reduce severe exacerbations by 50-70%
  • Enables oral corticosteroid dose reduction or elimination
  • Chinese biosimilar and locally-manufactured biologics offer major cost savings
  • Biomarker-guided selection ensures appropriate patient matching
Considerations
  • Injection site reactions in 5-10% of patients
  • Rare anaphylactic reactions require clinic observation
  • Not all patients respond to first biologic selected
  • Long-term immunomodulatory effects still being studied
下一步Next step

Ask the AI for hospitals that handle asthma biologics treatment.

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.